Division of Hematology and Clinical Immunology
271 – 280 of 779
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
- Contribution to journal › Article
-
Mark
SHARPIN stabilizes estrogen receptor a and promotes breast cancer cell proliferation
- Contribution to journal › Article
-
Mark
The Vel blood group system : a review
- Contribution to journal › Scientific review
-
Mark
Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach
- Contribution to journal › Letter
-
Mark
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
- Contribution to journal › Scientific review
- 2016
-
Mark
Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
- Contribution to journal › Article
-
Mark
Adverse events in apheresis: An update of the WAA registry data.
- Contribution to journal › Scientific review
-
Mark
Fetal and neonatal alloimmune thrombocytopenia.
- Contribution to journal › Scientific review
-
Mark
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
- Contribution to journal › Article
-
Mark
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
- Contribution to journal › Article